Clinical Trials in Texas

Showing 8081-8100 of 15,101 trials

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

NCT03625622

A double-blinded, randomized, placebo-controlled study will be performed to evaluate the efficacy and safety of treating AR1001 in patients with mild to moderate Alzheimer's disease for 26 weeks.

Mild to Moderate Alzheimer's Disease

AriBio Co., Ltd.210 participantsStarted Apr 2019

Banning, California, United States • Sacramento, California, United States • Santa Ana, California, United States +18 more locations

COMPLETEDPhase 343 miles

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03127956

The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris

Acne Vulgaris

Dermira, Inc.748 participantsStarted Mar 2017

Guntersville, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +91 more locations

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Find Trials by Condition in Texas

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Phase 2/3 Study of IGSC, 20% in PIDD

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Safety Study for Beta Thalassemia Subjects on PTG-300